Lowering Prescription Drug Costs: Biden-Harris Administration Takes Action
Michigan Congresswoman Hillary Scholten recently joined healthcare advocates and Protect Our Care Michigan to discuss the Biden-Harris administration’s plans to lower prescription drug costs. The administration has released the final guidance for the Inflation Reduction Act‘s Medicare Drug Price Negotiation Program, outlining the process for negotiation. By September 1, the ten drugs selected for the first round of price negotiations will be announced.
Speakers Highlight the Benefits for Michiganders
Congresswoman Scholten and other speakers discussed a new fact sheet from Protect Our Care that outlines how the Inflation Reduction Act reduces healthcare costs for Michiganders. The law gives Medicare the power to negotiate and cap seniors’ prescription drug costs, aiming to provide even more savings.
Protect Our Care Fact Sheet by WXMI on Scribd
Republicans and Big Pharma’s Opposition
Advocates claim that Republicans and big drug companies are attacking the Inflation Reduction Act in Congress and the courts. Pharmaceutical giants like Merck, Bristol Myers Squibb, Astellas Pharma, and Johnson & Johnson-owned Janssen Pharmaceuticals are focused on undermining the act by filing lawsuits to protect their profits. Congresswoman Scholten criticized her Republican colleagues for siding with Big Pharma and prioritizing profits over people.
Despite opposition, the Inflation Reduction Act is already providing savings on prescription drugs for Michiganders. Out-of-pocket costs for seniors will be capped at $2,000 per year, benefiting over 672,000 people in Michigan. Congresswoman Scholten pledges to continue working to keep costs low and expand these money-saving provisions.
Read More of this Story at www.fox17online.com – 2023-07-20 23:38:23
Read More US Economic News
